Authors:
EYBL V
CAISOVA D
KOTYZOVA D
KOUTENSKY J
KONTOGHIORGHES GJ
Citation: V. Eybl et al., INFLUENCE OF SOME CHELATORS ON LIPID-PEROXIDATION, GSH DEPLETION AND TRACE-ELEMENTS LEVEL IN THE LIVER OF MICE, Naunyn-Schmiedeberg's archives of pharmacology, 356(4), 1997, pp. 246-246
Citation: Gj. Kontoghiorghes, COMPARATIVE EFFICACY AND TOXICITY OF DESFERRIOXAMINE, DEFERIPRONE ANDOTHER IRON AND ALUMINUM CHELATING DRUGS, Toxicology letters, 80(1-3), 1995, pp. 1-18
Citation: Gj. Kontoghiorghes et Ed. Weinberg, IRON - MAMMALIAN DEFENSE SYSTEMS, MECHANISMS OF DISEASE, AND CHELATION-THERAPY APPROACHES, Blood reviews, 9(1), 1995, pp. 33-45
Authors:
KONTOGHIORGHES GJ
BARTLETT AN
SHEPPARD L
BARR J
NORTEY P
Citation: Gj. Kontoghiorghes et al., ORAL IRON CHELATION-THERAPY WITH DEFERIPRONE - MONITORING OF BIOCHEMICAL, DRUG AND IRON EXCRETION CHANGES, Arzneimittel-Forschung, 45-1(1), 1995, pp. 65-69
Citation: Gj. Kontoghiorghes, NEW CONCEPTS OF IRON AND ALUMINUM CHELATION-THERAPY WITH ORAL L1 (DEFERIPRONE) AND OTHER CHELATORS - A REVIEW, Analyst, 120(3), 1995, pp. 845-851
Citation: Gj. Kontoghiorghes et al., STUDIES OF ALUMINUM MOBILIZATION IN RECTAL DIALYSIS PATIENTS USING THE ORAL CHELATOR 1,2-DIMETHYL-3-HYDROXYPYRID-4-ONE, Arzneimittel-Forschung, 44-1(4), 1994, pp. 522-526